Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BALCHEM CORP Director's Dealing 2024

Mar 12, 2024

31041_dirs_2024-03-12_ac14414c-32f7-49c8-a5e6-a4539e4d0ba3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BALCHEM CORP (BCPC)
CIK: 0000009326
Period of Report: 2024-03-08

Reporting Person: Tignor Michael Brent (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-03-08 Common Stock M 4200 $85.4 Acquired 13707 Direct
2024-03-08 Common Stock S 3261 $157.0675 Disposed 10446 Direct
2024-03-08 Common Stock S 2078 $158.2233 Disposed 8368 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-03-08 Stock Options (right to buy) $85.4 M 4200 Disposed 2027-02-21 Common Stock (4200) Direct

Footnotes

F1: Exercise of fully vested non-qualified stock options.

F2: Includes acquisition of shares (company match) under the Balchem Corporation 401(k) plan.

F3: This transaction was executed in multiple sales ranging from $157.0000 to $157.1900 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.

F4: This transaction was executed in multiple sales ranging from $158.0000 to $158.7850 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.

F5: Stock options that vested 20% on February 21, 2018, 40% on February 21, 2019, and 40% on February 21, 2020, and are exercisable.